Mosseri Marlio Charles's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed Jun 20, 2025
- Accession no.
- 0001104659-25-060965
- Filed
- Jun 20, 2025
- Trade date
- Jun 17-18, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $269.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | Common Stock | PPurchaseAcquired | +5,399 | $8.11 | +$43,785.89 | 2,948,160 | Indirect | |
| Jun 18, 2025 | Common Stock | PPurchaseAcquired | +28,043 | $8.05 | +$225,746.15 | 2,976,203 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.